{
  "symbol": "ECL",
  "year": 2023,
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1716,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.134
  },
  "top_positive": [
    {
      "sent": "\u200b 56 Table of Contents CONSOLIDATED STATEMENTS OF EQUITY \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b Year ended December 31, 2021, 2020 and 2019 (millions, except per share amounts) Common Stock Additional Paid-in Capital Retained Earnings AOCI (Loss) Treasury Stock Ecolab Shareholders' Equity Non-Controlling Interest Total Equity Balance, December\u00a031, 2019 \u200b \u200b $ 359.6 \u200b $ 5,907.1 \u200b $ 9,993.7 \u200b ($ 2,089.7 ) \u200b ($ 5,485.4 ) \u200b $ 8,685.3 \u200b $ 40.5 \u200b $ 8,725.8 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b New accounting guidance adoption (a) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 4.3 ) \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 4.3 ) \u200b \u200b \u200b ( 4.3 ) Net (loss) income \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 1,205.1 ) \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 1,205.1 ) \u200b 19.6 \u200b ( 1,185.5 ) Other comprehensive income (loss) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 95.3 \u200b \u200b \u200b \u200b 95.3 \u200b 1.8 \u200b 97.1 Cash dividends declared (b) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 541.3 ) \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 541.3 ) \u200b ( 21.0 ) \u200b ( 562.3 ) Separation of ChampionX \u200b \u200b \u200b \u200b \u200b ( 8.5 ) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 1,051.4 ) \u200b \u200b ( 1,059.9 ) \u200b \u200b 3.4 \u200b \u200b ( 1,056.5 ) Changes in noncontrolling interests \u200b \u200b \u200b \u200b \u200b 17.6 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 17.6 \u200b \u200b ( 9.3 ) \u200b \u200b 8.3 Stock options and awards \u200b 3.0 \u200b \u200b 318.8 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 3.3 \u200b 325.1 \u200b \u200b \u200b \u200b 325.1 Reacquired shares \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 146.2 ) \u200b ( 146.2 ) \u200b \u200b \u200b \u200b ( 146.2 ) Balance, December\u00a031, 2020 \u200b 362.6 \u200b 6,235.0 \u200b 8,243.0 \u200b ( 1,994.4 ) \u200b ( 6,679.7 ) \u200b 6,166.5 \u200b 35.0 \u200b 6,201.5 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b Net income \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 1,129.9 \u200b \u200b \u200b \u200b \u200b \u200b \u200b 1,129.9 \u200b 14.1 \u200b 1,144.0 Other comprehensive income (loss) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 359.6 \u200b \u200b \u200b \u200b 359.6 \u200b ( 3.2 ) \u200b 356.4 Cash dividends declared (b) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 558.4 ) \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 558.4 ) \u200b ( 17.0 ) \u200b ( 575.4 ) Stock options and awards \u200b 1.5 \u200b \u200b 229.6 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 2.1 \u200b 233.2 \u200b \u200b \u200b \u200b 233.2 Reacquired shares \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 106.6 ) \u200b ( 106.6 ) \u200b \u200b \u200b \u200b ( 106.6 ) Balance, December\u00a031, 2021 \u200b 364.1 \u200b 6,464.6 \u200b 8,814.5 \u200b ( 1,634.8 ) \u200b ( 6,784.2 ) \u200b 7,224.2 \u200b 28.9 \u200b 7,253.1 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b Net income \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 1,091.7 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 1,091.7 \u200b \u200b 17.2 \u200b \u200b 1,108.9 Other comprehensive income (loss) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 91.8 ) \u200b \u200b \u200b \u200b ( 91.8 ) \u200b ( 4.2 ) \u200b ( 96.0 ) Cash dividends declared (b) \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 587.4 ) \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 587.4 ) \u200b ( 20.0 ) \u200b ( 607.4 ) Fair value adjustment of prior acquisition \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b - \u200b \u200b 0.6 \u200b \u200b 0.6 Stock options and awards 0.6 \u200b \u200b 115.6 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b 1.4 \u200b 117.6 \u200b \u200b \u200b \u200b 117.6 Reacquired shares \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b ( 518.2 ) \u200b ( 518.2 ) \u200b \u200b \u200b \u200b ( 518.2 ) Balance, December\u00a031, 2022 \u200b \u200b $ 364.7 \u200b \u200b $ 6,580.2 \u200b \u200b $ 9,318.8 \u200b \u200b ($ 1,726.6 ) \u200b \u200b ($ 7,301.0 ) \u200b \u200b $ 7,236.1 \u200b \u200b $ 22.5 \u200b \u200b $ 7,258.6 \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b (a) In 2020, upon adoption of ASU 2016-13, Financial Instruments \u2013 Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company reclassified the cumulative effect of applying the standard to retained earnings at the beginning of the period adopted.",
      "score": 0.9823
    },
    {
      "sent": "Ft.) Segment Majority Owned or Leased Fresno, TX USA 192,000 Global Industrial Owned Santiago, CHILE \u200b 188,000 \u200b Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences \u200b Owned Las Americas, DOMINICAN REPUBLIC 182,000 Global Institutional & Specialty, Global Healthcare & Life Sciences Owned Jacksonville, FL USA 181,000 Global Institutional & Specialty, Global Healthcare & Life Sciences Leased Garyville, LA USA 178,000 Global Industrial Owned Gul Lane, SINGAPORE \u200b 169,000 \u200b Global Industrial Owned Nieuwegein, NETHERLANDS 168,000 Global Institutional & Specialty, Global Industrial Owned La Romana, DOMINICAN REPUBLIC 160,000 Global Institutional & Specialty, Global Healthcare & Life Sciences Leased Middleton, UNITED KINGDOM \u200b 157,575 \u200b Global Industrial, Global Healthcare & Life Sciences \u200b Owned Tessenderlo, BELGIUM 153,000 Global Institutional & Specialty, Global Industrial Owned Cheltenham, AUSTRALIA 145,000 Global Institutional & Specialty, Global Industrial Owned Suzano, BRAZIL 142,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Owned McDonough, GA USA 141,000 Global Institutional & Specialty, Global Industrial Owned Darra, AUSTRALIA 138,000 Global Institutional & Specialty, Global Industrial Owned Burlington, ON CANADA 136,000 Global Industrial Owned Eagan, MN USA 133,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences, Other Owned Huntington,\u00a0IN USA 127,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Owned Rozzano,\u00a0ITALY 126,000 Global Institutional & Specialty, Global Industrial Owned City of Industry, CA USA 125,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Owned Mississauga, ON CANADA 120,000 Global Institutional & Specialty, Global Industrial Leased Elk Grove Village,\u00a0IL USA 115,000 Global Institutional & Specialty Leased Biebesheim, GERMANY 109,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Owned Fort Worth, TX USA 101,000 Global Institutional & Specialty Leased Johannesburg, SOUTH AFRICA 100,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Owned Andover, UNITED KINGDOM \u200b 99,762 \u200b Global Industrial, Global Healthcare & Life Sciences \u200b Owned Pilar, ARGENTINA \u200b 96,000 \u200b Global Institutional & Specialty, Global Industrial \u200b Owned Hamilton, NEW ZEALAND 96,000 Global Institutional & Specialty, Global Industrial Owned Konnagar, INDIA \u200b 88,000 \u200b Global Industrial Owned Kwinana, AUSTRALIA 87,000 Global Institutional & Specialty, Global Industrial Owned Yangsan, KOREA 85,000 Global Industrial Owned Cuautitlan, MEXICO 76,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Owned Barueri, BRAZIL 75,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Leased Citereup, INDONESIA \u200b 74,000 \u200b Global Industrial \u200b Owned King of Prussia, PA \u200b 74,000 \u200b Global Healthcare & Life Sciences \u200b Owned Mullingar, IRELAND 74,000 Global Institutional & Specialty, Global Industrial Leased Mosta, MALTA 73,000 Global Institutional & Specialty, Global Healthcare & Life Sciences Leased Aubagne,\nity Owned or Leased Verona, ITALY 55,000 Global Institutional & Specialty, Global Healthcare & Life Sciences Owned Guangzhou, CHINA 55,000 Global Institutional & Specialty, Global Industrial Owned Navanakorn, THAILAND 53,000 Global Institutional & Specialty, Global Industrial Leased Lerma, MEXICO 49,000 Global Industrial Owned Maribor, SLOVENIA 46,400 Global Institutional & Specialty, Global Industrial Owned Leeds, UNITED KINGDOM 25,000 Global Institutional & Specialty Owned Baglan, UNITED KINGDOM 24,400 Global Institutional & Specialty, Global Healthcare & Life Sciences Leased Noda, JAPAN 22,000 Global Institutional & Specialty, Global Industrial, Global Healthcare & Life Sciences Owned \u200b Generally, our manufacturing facilities are adequate to meet our existing in-house production needs.",
      "score": 0.9732
    },
    {
      "sent": "\u200b Issuer Purchases of Equity Securities \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b \u200b Total number\u00a0of\u00a0shares \u200b Maximum\u00a0number\u00a0of \u200b \u200b \u200b \u200b \u200b \u200b purchased\u00a0as\u00a0part\u00a0of \u200b shares\u00a0that\u00a0may\u00a0yet\u00a0be \u200b \u200b Total\u00a0number\u00a0of \u200b Average\u00a0price\u00a0paid \u200b publicly\u00a0announced \u200b purchased\u00a0under\u00a0the Period \u200b shares\u00a0purchased (1) \u200b per\u00a0share (2) \u200b plans\u00a0or\u00a0programs (3) \u200b plans\u00a0or\u00a0programs (3) October 1-31, 2022 1,362 \u200b \u200b $157.0872 \u200b - 3,404,297 \u200b November 1-30, 2022 487,200 \u200b \u200b 147.8301 \u200b 487,200 12,917,097 \u200b December 1-31, 2022 3,723 \u200b \u200b 149.8621 \u200b - 12,917,097 \u200b Total 492,285 \u200b \u200b $147.8711 487,200 12,917,097 \u200b \u200b (1) Includes 5,085 shares reacquired from employees and/or directors to satisfy the exercise price of stock options or shares surrendered to satisfy statutory tax obligations under our stock incentive plans.",
      "score": 0.9674
    }
  ],
  "top_negative": [
    {
      "sent": "\u200b The occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) repeated or prolonged federal government shutdowns or similar events, (d) war (including acts of terrorism or hostilities which impact our markets), (e) natural or manmade disasters, (f) water shortages or (g) severe weather conditions affecting our operations or the energy, foodservice, hospitality and travel industries may have a material adverse effect on our business.",
      "score": -0.9657
    },
    {
      "sent": "\u200b The occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) repeated or prolonged federal government shutdowns or similar events, (d) war (including acts of terrorism or hostilities which impact our markets), (e) natural or manmade disasters, (f) water shortages or (g) severe weather conditions affecting our operations or the energy, foodservice, hospitality and travel industries may have a material adverse effect on our business.",
      "score": -0.9657
    },
    {
      "sent": "\u200b The occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) repeated or prolonged federal government shutdowns or similar events, (d) war (including acts of terrorism or hostilities which impact our markets), (e) natural or manmade disasters, (f) water shortages or (g) severe weather conditions affecting our operations or the energy, foodservice, hospitality and travel industries may have a material adverse effect on our business.",
      "score": -0.9657
    }
  ],
  "forward_snippets": [
    "By partnering with our customers to help them do more with less through the use of our innovative and differentiated solutions, we aim to help our customers conserve more than 300 billion gallons of water annually by 2030.",
    "By partnering with our customers to help them do more with less through the use of our innovative and differentiated solutions, we aim to help our customers conserve more than 300 billion gallons of water annually by 2030.",
    "By partnering with our customers to help them do more with less through the use of our innovative and differentiated solutions, we aim to help our customers conserve more than 300 billion gallons of water annually by 2030.",
    "\u200b We believe we are one of the leading global suppliers of products and programs for chemical applications within the industrial water treatment industry.",
    "\u200b We believe we are one of the leading global suppliers of cleaning and sanitizing products to the dairy plant, dairy, swine and poultry farm, beverage/brewery, food, meat and poultry, and beverage/brewery processing industries."
  ]
}